Smoore 2024 Earnings Report: Revenue Up 5% to $1.63 Billion, Net Profit Down 20% to $180 Million

Mar.18

Smoore reported a 5.3% year-on-year increase in total revenue to 11.799 billion yuan ($1.63 billion) for 2024. Net profit dropped approximately 20% to 1.303 billion yuan ($180 million). Revenue from its self-owned brand business grew 34% to 2.475 billion yuan ($340 million), accounting for 21% of total revenue.

2Firsts, reporting from Shenzhen - On the evening of March 17, Smoore International Holdings Limited (referred to as "Smoore", stock code: 6969) released its 2024 earnings report.

According to the financial report, Smoore reported a total revenue of 11.799 billion yuan (about $1.63 billion) in 2024, marking a 5.3% increase from the previous year. However, net profit fell by about 20% to around 1.3 billion yuan (around $180 million).

Revenue from Smoore’s self-owned brand business reached 2.475 billion yuan (around $340 million), accounting for 21% of total revenue, up 34% year-on-year.

Revenue from corporate client oriented business totaled 9.324 billion yuan (about $1.29 billion), making up 79% of total revenue, down 0.3% from the previous year.

Speifically, Smoore's revenue from Europe and other markets rose 8.7% year-on-year to 5.512 billion yuan (around $760 million), making up 46.7% of total revenue. U.S. revenue climbed 15.5% to 1.399 billion yuan (about $190 million), accounting for 11.9%.

Mainland of China revenue increased 12.9% to 1.011 billion yuan (around $140 million), representing 8.6% of the total. Revenue from Hong Kong, China, however, fell 3.7% to 3.876 billion yuan (around $540 million), contributing 32.8% to overall revenue.

In addition, Smoore's research and development expenses rose 6% year-on-year to 1.57 billion yuan (about $220 million) in 2024, accounting for 13.3% of total revenue. The increase was mainly driven by investment in medical atomization and heated tobacco (heat-not-burn) products.

The management expressed confidence in the company's long-term growth and stated that they will continue to focus on the core technology of atomization, expanding their business in areas such as electronic atomization, HNB (heat-not-burn) products, special purpose atomization products, inhalation therapy, and beauty atomization.

The company plans to further optimize collaboration models by 2025, offering more customized services to meet rapidly changing market demands.

2Firsts will provide an analysis of Smoore International's 2024 annual report. Stay tuned.

References:

[1] 思摩尔国际截至2024年12月31日止年度業績公告

Also Read:

[1] Smoore's Q2 2023 Financial Report: Revenue Decline and Profit Increase

[2] Data | Smoore Interim Financial Report: 2-Year Decline in Sales Revenue, Pod-System Surge 22.5% in Europe and Other Markets

[3] Analysis and Highlights of Smoore International's 2024 Interim Report

[4] Smoore 2024 Interim Financial Report: 71.9% Growth in Proprietary Brand Business, 12.3% Decline in Corporate Client Revenue

[5] Smoore's 2023 Annual Performance: Strong Growth and Global Expansion

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Kenya Court of Appeal Halts BBC Defamation Case Linked to BAT Bribery Documentary

Kenya’s Court of Appeal has paused the defamation proceedings filed by National Assembly Speaker Moses Wetang’ula against the BBC. The case centers on a 2015 BBC documentary, Panorama: The Secret Bribes of Big Tobacco, which alleged that Wetang’ula received unlawful benefits from British American Tobacco (BAT) during his tenure as a senator.

Dec.02 by 2FIRSTS.ai

Product | Compatible with Terea Sticks and Supporting Dual Heating: HiTaste Unveils New Heated Tobacco Device

HiTaste has introduced its new HNB device, the F10, on social media, highlighting its wrap-around heating and dual-heating features. Similar “dual-heating” and “one-stick-two-sessions” designs were widely showcased at InterTabac 2025, signaling that this technical direction is emerging as a new competitive focus among HNB brands.

Nov.17 by 2FIRSTS.ai

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.

Nov.26

New Zealand Survey Finds Adult Daily Vaping Prevalence at 11.7%, Concentrated Among Youth and Disadvantaged Groups）

A survey report released by the Public Health Communication Centre Aotearoa shows that despite New Zealand implementing stricter vaping regulations in 2025, including a ban on disposable products and tighter flavour restrictions, daily vaping rates continue to rise. The research body urges close monitoring of behavioural changes following the new rules coming into force.